Page 3 - Safety Technical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CDC Warns Of Possible Side Effects From Second Vaccine Dose The Center For Disease Control and Prevention has issued a warning for young teens and adolescents following the second dose of the Covid-19 vaccine which has shown in some rare instances to cause inflammation around the heart, myocarditis. Jeeez, if people didn't have already vaccine hesitancy, they will after reading this update from the CDC. Get our free mobile app   The Centers for Disease Control and Prevention is investigating a rare heart condition possibly linked to adolescents and young adults getting the vaccine, accordi...

May 24, 2021 Agencies in the United States and Europe are assessing reports of myocarditis developing in people who have received one of the mRNA-based COVID-19 vaccines, although no definitive link has yet been established. The US Centers for Disease Control and Prevention (CDC) recently alerted clinicians to the possible association, with the COVID-19 Vaccine Safety Technical (VaST) work group of its Advisory Committee on Immunization Practices releasing a brief report last week. The group heard about the “relatively few reports of myocarditis” based on data from the Department of Defen...

Lynn Sutfin LANSING — The Michigan Department of Health and Human Services is recommending vaccine providers across the state resume the use of Johnson & Johnson vaccine to vaccinate Michiganders age 18 and older. This recommendation is based on the U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention (CDC) recommending to move forward with administering the vaccine. The agencies previously recommended a pause on Apr. 13 while experts conducted a thorough safety review after reports of a rare blood clotting syndrome in some people. “We are glad...

Written by Food & Drug Administration Following a thorough safety review, including two meetings of the CDC’s Advisory Committee on Immunization Practices, the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Johnson & Johnson (Janssen) COVID-19 Vaccine in the U.S. should be lifted and use of the vaccine should resume. The pause was recommended after reports of six cases of a rare and severe type of blood clot in individuals following administration of the Janssen COVID-19 Vacc...

Share this article Share this article SILVER SPRING, Md., April 23, 2021 /PRNewswire/ -- Following a thorough safety review, including two meetings of the CDC's Advisory Committee on Immunization Practices, the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Johnson & Johnson (Janssen) COVID-19 Vaccine in the U.S. should be lifted and use of the vaccine should resume. The pause was recommended after reports of six cases of a rare and severe type of blood clot in individuals following ...